Permian Leverage and the CrownRock Integration Story

Occidental Petroleum Corporation is an international energy company with three primary segments:

• Oil and Gas (Upstream): The dominant earnings driver. Operations span the Permian Basin (the core of the portfolio post-CrownRock), the Denver-Julesburg Basin, the Gulf of Mexico, and international assets in Oman, the UAE, and Algeria. Total company production runs in the range of 1.4 million boe/d, with oil representing a majority of the mix — a critical detail, since oil realizations drive the majority of cash flow.
• OxyChem (Chemicals): A chlorovinyls producer making PVC, caustic soda, and related products. This segment sells into construction, water treatment, and industrial end markets, and is a genuine non-oil cash generator.
• Midstream and Marketing: Gathering, processing, and transportation infrastructure, plus domestic and international marketing of oil, gas, and power. Much of this supports upstream operations but also generates third-party revenue.

How it makes money: Primarily by selling crude oil, natural gas liquids, and natural gas at prevailing market prices, with realizations tied to benchmarks (WTI, Brent, Henry Hub) adjusted for location and quality differentials. Chemicals revenue is contract- and spot-priced against PVC and caustic benchmarks. Midstream earns fee-based and margin-based revenue.

Customers: Refiners, petrochemical companies, utilities, industrial manufacturers, and trading counterparties. No single customer concentration is material to the consolidated story.

Scale: $60.5B market cap, 999.64M shares outstanding, 995.56M public float, and average daily volume of 8.57M shares — liquid enough for institutional positioning.

Near-term (next 12–24 months):

• CrownRock integration and synergy capture. The primary near-term lever is realizing the operating and G&A synergies from CrownRock and translating them into lower per-barrel costs and higher free cash flow.
• Debt reduction. Free cash flow directed to the balance sheet reduces interest expense and improves credit metrics, which is the mechanism that unlocks future shareholder returns.
• OxyChem margin normalization. PVC and caustic pricing are cyclical; a recovery in construction-linked demand would lift Chemicals EBITDA without requiring incremental capital.
• Permian efficiency gains. Longer laterals, simul-fracs, and digital/automation initiatives continue to lower development cost per barrel.

Medium-term (3–5 years):

• Inventory depth. CrownRock's ~1,700 undeveloped locations extend the Permian runway, supporting flat-to-modest production growth with disciplined capital.
• Low-carbon ventures optionality. OXY has invested in direct air capture (DAC) and related low-carbon businesses. These are currently a cash use, not a cash generator, and should be modeled as optionality rather than a near-term earnings driver. Any commercial-scale success would be a call option on the equity.
• Capital return inflection. Once leverage targets are met, the free cash flow that has been going to debt can be redirected to buybacks and dividends, which is the most plausible path to multiple expansion.

Note: Forward figures are illustrative analyst projections based on current strip pricing assumptions and should be treated as directional, not precise. Trailing EPS per the live data feed is $3.39.

The narrative is straightforward: 2022 was a peak-crude windfall year that generated enormous free cash flow and rapid deleveraging. Since then, lower oil prices and the CrownRock acquisition have compressed both earnings and free cash flow, temporarily pushing leverage back up. The forward path depends almost entirely on (a) where crude settles, and (b) how quickly CrownRock synergies and capital discipline convert into debt paydown. Chemicals provides a modest stabilizer but is itself mid-cycle.

Market context: Global oil demand remains the anchor of the upstream industry, with the Permian Basin the single most important supply growth region outside OPEC. The addressable opportunity for a Permian-weighted independent is effectively the global crude market, but competitive advantage is determined at the basin level — by acreage quality, breakeven cost, and capital efficiency.

Competitive positioning:

• OXY holds top-tier Permian acreage, particularly after CrownRock, with a deep undeveloped inventory.
• Its integrated Chemicals and Midstream segments differentiate it from pure-play Permian E&Ps.
• Its leverage profile and the Berkshire preferred/common overhang are relative negatives versus cleaner-balance-sheet peers.

Named comparables:

OXY's differentiation is its Permian concentration plus Chemicals optionality; its handicap is leverage. The competitive question is whether it can close the leverage gap fast enough for the market to stop applying a discount.

DCF discussion: A discounted cash flow model for OXY is highly sensitive to the crude price deck. Using a mid-cycle WTI assumption in the $70–75 range, flat-to-slightly-growing production near 1.45 MMboe/d, and segment-level EBITDA margins, the company generates roughly $5B of annual free cash flow at mid-cycle. Discounting that stream at a weighted average cost of capital in the 9–11% range (reflecting the levered balance sheet and the low observed equity beta of 0.16, which arguably understates true commodity risk), and applying a terminal value based on a modest decline in long-run cash flows, produces an equity value that brackets the current $60.82 price — with the upside case dependent on faster deleveraging and a narrowing of the peer multiple gap. The DCF is a sanity check here, not a precision instrument; the comparable multiples below are the more actionable frame.

Comparable multiples:

OXY multiples derived from the live data: $60.82 price / $3.39 EPS ≈ 17.9x trailing P/E; EV/EBITDA estimated from $60.5B market cap plus net debt against ~$13B EBITDA. Peer figures are approximate sector averages and intended for relative context.

The read-through: OXY screens expensive on trailing P/E (depressed earnings base) but roughly in line to slightly cheap on EV/EBITDA once leverage is normalized. The re-rating case rests on debt reduction closing the gap to COP and FANG.

• Commodity price risk: OXY's cash flow is overwhelmingly driven by crude oil realizations. A sustained move in WTI below $60 would pressure free cash flow, slow deleveraging, and likely compress the equity toward the lower end of its 52-week range.
• Leverage and capital structure risk: The balance sheet carries more debt than large-cap peers, and the Berkshire preferred dividend is a fixed cash obligation. If oil weakens while leverage is still elevated, the company faces a genuine tension between debt reduction, dividends, and capital spending.
• Integration and execution risk: CrownRock synergies are a projection, not a certainty. Underdelivery on cost savings or inventory quality would undermine the core thesis.
• Regulatory and permitting risk: Permian operations face ongoing federal and state regulatory scrutiny on emissions, water disposal, and permitting. Tightening rules raise costs or slow development.
• Low-carbon venture capital risk: DAC and related investments consume capital today with uncertain commercial returns. Continued funding in a weak oil environment could be a drag on free cash flow and a source of shareholder friction.
• Concentration/overhang risk: Berkshire Hathaway's substantial preferred and common position is a structural feature of the equity that can cap upside and complicate capital structure decisions.